Effectiveness of combination therapies in asthma: An observational study

Pulmonary Pharmacology and Therapeutics

Volumn 22, Issue 3, 2009, Pages 194-198

  Suissa, Samy ^a,b   Dell'Aniello, Sophie ^a   Ernst, Pierre ^a,b  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Asthma; Bronchodilators; Drug therapy; Inhaled corticosteroids

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE PLUS FORMOTEROL; CORTICOSTEROID; FLUTICASONE PROPIONATE PLUS SALMETEROL;

ADULT; ARTICLE; ASTHMA; CLINICAL EFFECTIVENESS; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; FEMALE; HEALTH CARE UTILIZATION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT REFERRAL; PRESCRIPTION; PRIORITY JOURNAL; TREATMENT DURATION; TREATMENT OUTCOME;

ADULT; ALBUTEROL; ANDROSTADIENES; ANTI-ASTHMATIC AGENTS; ANTI-INFLAMMATORY AGENTS; ASTHMA; BRONCHODILATOR AGENTS; BUDESONIDE; COHORT STUDIES; DATABASES, FACTUAL; DRUG COMBINATIONS; DRUG THERAPY, COMBINATION; ETHANOLAMINES; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 67349152617     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2008.11.008     Document Type: Article

References (13)

1. Expert Panel Report 3 (EPR-3): Guidelines for the diagnosis and management of asthma - summary report 2007. J Allergy Clin Immunol 2007;120(5 Suppl):S94-138.
2. Global Initiative for Asthma. Pocket guide for asthma management and prevention. 2006.
3. Lemiere C., Bai T., Balter M., Bayliff C., Becker A., Boulet L.P., et al. Adult asthma consensus guidelines update 2003. Can Respir J 11 Suppl A (2004) 9A-18A
4. Greenstone I.R., Ni Chroinin M.N., Masse V., Danish A., Magdalinos H., Zhang X., et al. Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma. Cochrane Database Syst Rev 4 (2005) CD005533
5. Lemanske Jr. R.F., Sorkness C.A., Mauger E.A., Lazarus S.C., Boushey H.A., Fahy J.V., et al. Inhaled corticosteroid reduction and elimination in patients with persistent asthma receiving salmeterol: a randomized controlled trial. JAMA 285 20 (2001) 2594-2603
6. Lazarus S.C., Boushey H.A., Fahy J.V., Chinchilli V.M., Lemanske Jr. R.F., Sorkness C.A., et al. Long-acting beta2-agonist monotherapy vs continued therapy with inhaled corticosteroids in patients with persistent asthma: a randomized controlled trial. JAMA 285 20 (2001) 2583-2593
7. Mann M., Chowdhury B., Sullivan E., Nicklas R., Anthracite R., and Meyer R.J. Serious asthma exacerbations in asthmatics treated with high-dose formoterol. Chest 124 1 (2003) 70-74
8. Boulet LP, Becker A, Berube D, Beveridge R, Ernst P. Canadian asthma consensus report, 1999. Canadian Asthma Consensus Group. Can Med Assoc J 1999;161(11 Suppl):S1-61.
9. National Asthma Education Program NHLBI. Practical guide for the diagnosis and management of asthma. US Department of Health and Human Services (1997) 1-52
10. Aalbers R., Backer V., Kava T.T., Omenaas E.R., Sandstrom T., Jorup C., et al. Adjustable maintenance dosing with budesonide/formoterol compared with fixed-dose salmeterol/fluticasone in moderate to severe asthma. Curr Med Res Opin 20 2 (2004) 225-240
11. Bateman E.D., Boushey H.A., Bousquet J., Busse W.W., Clark T.J., Pauwels R.A., et al. Can guideline-defined asthma control be achieved?: The Gaining Optimal Asthma ControL Study. Am J Respir Crit Care Med 170 8 (2004) 836-844
12. Garcia Rodriguez L.A., and Perez G.S. Use of the UK General Practice Research Database for pharmacoepidemiology. Br J Clin Pharmacol 45 5 (1998) 419-425
13. Jick S.S., Kaye J.A., Vasilakis-Scaramozza C., Garcia Rodriguez L.A., Ruigomez A., Meier C.R., et al. Validity of the general practice research database. Pharmacotherapy 23 5 (2003) 686-689